Absence of PMS2 mutations in colon‐CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression. (27th September 2012) - Clendenning, M; Macrae, FA; Walsh, MD; Walters, RJ; Thibodeau, SN; Gunawardena, SR; Potter, JD; Haile, RW; Gallinger, S; ,; Hopper, JL; Jenkins, MA; et al.